Anixa Biosciences is trading 5.6% up now at $3.36, with no clear company-specific catalyst identified for August 17, 2026.

  • Recent coverage references CEO Amit Kumar’s purchase of 5,000 shares.
  • The transaction occurred July 31 and was reported August 3, making it insufficient to explain the current move directly.
  • Broader indexes are nearly flat, so the reason for the increase remains unclear.